Telomir Advances Cancer Pipeline with FDA Clearance for Telomir-Zn
First-in-human trial targets aggressive triple-negative breast cancer with novel epigenetic approach Telomir Pharmaceuticals (TELO) has reached a key milestone in ...
Tag: TELO
Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model
Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a ...
Institutional Interest In Telomir Pharmaceuticals
Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position ...
Telomir Pharmaceuticals Achieves Breakthrough in Silver-Based Medical Science
Stabilizing Silver(II) for Enhanced Antimicrobial and Wound Healing Applications Telomir Pharmaceuticals (TELO) has announced a groundbreaking scientific achievement—its proprietary compound, ...
Telomir Pharmaceuticals Unveils Groundbreaking Results with Telomir-1: A New Hope for Combating Oxidative Stress and Viral Infections
Innovative drug shows potential to address aging, chronic diseases, and avian influenza through oxidative stress reversal Telomir Pharmaceuticals (TELO), a ...
Telomir Pharmaceuticals Unveils Groundbreaking Progeria Treatment in Preclinical Study
Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has ...
Telomir Pharmaceuticals Advances Groundbreaking Research in Copper-Binding Therapies for Wilson’s Disease
Emerging Findings Position Telomir-1 as a Promising Solution for Copper Metabolism Disorders and Expand Its Potential Applications Telomir Pharmaceuticals (TELO), ...
